Amikacin Liposome
Risk of Increased Respiratory Adverse Reactions
- ARIKAYCE has been associated with a risk of increased respiratory adverse reactions, including, hypersensitivity pneumonitis, hemoptysis, bronchospasm, and exacerbation of underlying pulmonary disease that have led to hospitalizations in some cases.
Patient Counseling Information
Medication Guides
Package Inserts
Additional Information
Updated October 2018